Publication:
Co-expression Network Analysis Elucidated a Core Module in Association With Prognosis of Non-functioning Non-invasive Human Pituitary Adenoma

dc.contributor.authorARĞA, KAZIM YALÇIN
dc.contributor.authorsAydin, Busra; Arga, Kazim Yalcin
dc.date.accessioned2022-03-14T09:07:20Z
dc.date.accessioned2026-01-11T11:37:20Z
dc.date.available2022-03-14T09:07:20Z
dc.date.issued2019-06-06
dc.description.abstractNon-functioning pituitary adenomas (NFPAs) are tumors with clinically challenging features since they have insidious progression. A complex network of gene interactions is thought to have roles in tumor formation and progression. Therefore, revealing the genetic network behind NFPA tumorigenesis is not only essential to attain further knowledge of tumor biology, but also plays a fundamental role in the development of efficacious treatment strategies. Differential co-expression network analysis is an outstanding approach for elucidation of groups of genes which show distinct co-expression patterns among phenotypes. In this study, we carried out a differential co-expression network analysis of NFPA-associated transcriptome dataset (n = 40) considering invasive (n = 22) and non-invasive (n = 18) phenotypes. Furthermore, we identified differentially co-expressed and co-regulated mRNA modules, which might be considered as potential systems biomarkers for NFPA prognosis and invasiveness. As a result, we have identified a novel 13-genemodule, including CEACAM6, CYP4B1, EIF2S2, HID1, IFFO1,MYO18A, PDCD2, SGIP1, SWSAP1, and four unknown genes (A_24_P127621, A_24_P255786, A_24_P683553, and A_24_P916979), which was able to categorize the patients into two groups as invasive and non-invasive NFPA with distinct prognosis. The prognostic core module genes were associated with progression and prognosis of brain and glandular based cancers as well. Furthermore, these module genes were also expressed in blood, salivary gland, and spinal cord tissues. These results may provide the evidence on featured gene module which might play a prominent role in NFPA prognosis and sub-typing as effective biomarkers and therapeutic targets in the future.
dc.identifier.doi10.3389/fendo.2019.00361
dc.identifier.issn1664-2392
dc.identifier.pubmed31244774
dc.identifier.urihttps://hdl.handle.net/11424/242572
dc.identifier.wosWOS:000471150100001
dc.language.isoeng
dc.publisherFRONTIERS MEDIA SA
dc.relation.ispartofFRONTIERS IN ENDOCRINOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectco-expression
dc.subjectdifferential co-expression network
dc.subjectnon-functional pituitary adenoma
dc.subjectinvasiveness
dc.subjectprognosis
dc.subjectbiomarker
dc.subjectGENE-EXPRESSION PROFILES
dc.subjectDOWN-REGULATION
dc.subjectCANCER
dc.subjectPROTEIN
dc.subjectTUMORS
dc.subjectCEACAM6
dc.subjectFAMILY
dc.subjectCLASSIFICATION
dc.subjectIDENTIFICATION
dc.subjectORGANIZATION
dc.titleCo-expression Network Analysis Elucidated a Core Module in Association With Prognosis of Non-functioning Non-invasive Human Pituitary Adenoma
dc.typearticle
dspace.entity.typePublication
oaire.citation.titleFRONTIERS IN ENDOCRINOLOGY
oaire.citation.volume10

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
3.83 MB
Format:
Adobe Portable Document Format